concentra on in systemic circula on for pharma¬cological response. Poor solubility of BCS class II and IV drugs is a ributable for delay or failure and due to this
dispersions have shown the potential to offer higher apparent solubility and bioavailability of BCS class II drugs. Drug stability, drug-polymer miscibility and drug supersaturation are the fundamental requirements
Purpose: Irbesartan is a BCS class II compound that exhibits pH– and buffer capacity–dependent dissolution behavior. The aim of this study was to apply non-linear mixed effects modelling
Dissolution of the BCS class II is dependent on the Gastrointestinal (GI) physiological factors. Surface Tension (ST) is a major characteristic of the GI fluids that can affect drug release ... range of 30-45 and…
Weakly acidic biopharmaceutics classification system (BCS) class II drugs may exhibit gastric supersaturation and precipitation. The objective of this study was to investigate the transfer behavior of the weakly acidic…
drug at physiological pH, poor permeation through biomembrane, extensive presystemic metabol ism. From BCS candidates, class II and class IV drugs have solubility and permeability problems because of which their…
vitro dissolution profile of BCS class II drug in biorelevant; compendial media was compared and the potential of different media was determined in predicting in vivo profile. The solubility
concentration in systemic circulation for pharmaÃ?Â?Ã?¬cological response. Poor solubility of BCS class II and IV drugs is attributable for delay or failure and due to this reason
volatile solvent which causes improved wettability. Progesterone (PG) is belonging to BCS class II which is commonly used orally as hormonal therapy in pregnancy and having less oral bioavailability. Hence
focusing on cyclodextrins as a solubilizing tool for their stubborn like bricks APIs (BCS class II and IV)). The reason is obvious: Easy to scale up and a successful presence
traditional and novel techniques that that can be used for solubility enhancement of BCS Class II drugs are briefly discussed in this article. The Traditional techniques that has been discussed
traditional and novel techniques that that can be used for solubility enhancement of BCS Class II drugs are briefly discussed in this article. The Traditional techniques that has been discussed
work was to improve the solubility and dissolution properties of a model BCS-Class-II drug by formulating nicotinamide co-crystal. We evaluated the effect of cocrystallization on the drug
dissolution of drug Celecoxib which is poorly water soluble as it belongs to BCS class II. Enhancement of solubility was be achieved by converting the BCS Class II drugs into
chemical entity (NCE), are facing the solubility problem [classified as biopharmaceutical classification system (BCS) Class II or IV]. Hence extensive development in solubility enhancement is required. Hot melt…
Ursodeoxycholic acid (UDCA) belongs to Biopharmaceutical Classification System (BCS) class II and hence exhibits low aqueous solubility and high permeability. Solubility of this drug is very low which affects
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.